Raymond James & Associates Cytokinetics Inc Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.05 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$874 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$714 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$466 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$380 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.61B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...